119 related articles for article (PubMed ID: 28653159)
1. Could a Feeding Jejunostomy be Integrated into a Standardized Preoperative Management of Oeso-gastric Junction Adenocarcinoma?
Manfredelli S; Delhorme JB; Venkatasamy A; Gaiddon C; Brigand C; Rohr S; Romain B
Ann Surg Oncol; 2017 Oct; 24(11):3324-3330. PubMed ID: 28653159
[TBL] [Abstract][Full Text] [Related]
2. How to Prevent Sarcopenia Occurrence during Neoadjuvant Chemotherapy for Oesogastric Adenocarcinoma?
Voisinet M; Venkatasamy A; Alratrout H; Delhorme JB; Brigand C; Rohr S; Gaiddon C; Romain B
Nutr Cancer; 2021; 73(5):802-808. PubMed ID: 32449415
[TBL] [Abstract][Full Text] [Related]
3. Management of Dysphagia in Esophageal Adenocarcinoma Patients Undergoing Neoadjuvant Chemotherapy: Can Invasive Tube Feeding be Avoided?
Cools-Lartigue J; Jones D; Spicer J; Zourikian T; Rousseau M; Eckert E; Alcindor T; Vanhuyse M; Asselah J; Ferri LE
Ann Surg Oncol; 2015; 22(6):1858-65. PubMed ID: 25476030
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of self-expanding removable metal esophageal stents during neoadjuvant chemotherapy for resectable esophageal cancer.
Pellen MG; Sabri S; Razack A; Gilani SQ; Jain PK
Dis Esophagus; 2012 Jan; 25(1):48-53. PubMed ID: 21595778
[TBL] [Abstract][Full Text] [Related]
5. Nutritional optimization during neoadjuvant therapy prior to surgical resection of esophageal cancer-a narrative review.
Huddy JR; Huddy FMS; Markar SR; Tucker O
Dis Esophagus; 2018 Jan; 31(1):1-11. PubMed ID: 29024949
[TBL] [Abstract][Full Text] [Related]
6. Laparoscopic feeding jejunostomy in esophagogastric cancer.
Jenkinson AD; Lim J; Agrawal N; Menzies D
Surg Endosc; 2007 Feb; 21(2):299-302. PubMed ID: 17122985
[TBL] [Abstract][Full Text] [Related]
7. Self-expanding plastic esophageal stents versus jejunostomy tubes for the maintenance of nutrition during neoadjuvant chemoradiation therapy in patients with esophageal cancer: a retrospective study.
Siddiqui AA; Glynn C; Loren D; Kowalski T
Dis Esophagus; 2009; 22(3):216-22. PubMed ID: 19207544
[TBL] [Abstract][Full Text] [Related]
8. Exclusive neoadjuvant chemotherapy in locally advanced resectable gastric and gastro-esophageal junction adenocarcinoma.
Fernandez E; Cacheux W; Frossard JL; Koessler T; Abou M; Moniez M; Huber O; Puppa G; Roth A
Dig Liver Dis; 2017 May; 49(5):552-556. PubMed ID: 28179095
[TBL] [Abstract][Full Text] [Related]
9. Pre-therapy laparoscopic feeding jejunostomy is safe and effective in patients undergoing minimally invasive esophagectomy for cancer.
Ben-David K; Kim T; Caban AM; Rossidis G; Rodriguez SS; Hochwald SN
J Gastrointest Surg; 2013 Aug; 17(8):1352-8. PubMed ID: 23709367
[TBL] [Abstract][Full Text] [Related]
10. Benefits of Supplemental Jejunostomy Tube Feeding During Neoadjuvant Therapy in Patients with Locally Advanced, Potentially Resectable Esophageal Cancer.
Dalton BGA; Friedant AJ; Su S; Schatz TAP; Ruth KJ; Scott WJ
J Laparoendosc Adv Surg Tech A; 2017 Dec; 27(12):1279-1283. PubMed ID: 28777676
[TBL] [Abstract][Full Text] [Related]
11. [Enteral nutrition at home with jejunostomy catheter].
Bodoky A; Dupont V; Heberer M; Harder F
Helv Chir Acta; 1990 Jun; 57(1):141-6. PubMed ID: 1699912
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma.
Park I; Ryu MH; Choi YH; Kang HJ; Yook JH; Park YS; Kim HJ; Jung HY; Lee GH; Kim KC; Kim BS; Kang YK
Cancer Chemother Pharmacol; 2013 Oct; 72(4):815-23. PubMed ID: 23921575
[TBL] [Abstract][Full Text] [Related]
13. Relief of dysphagia during neoadjuvant treatment for cancer of the esophagus or gastroesophageal junction.
Sunde B; Ericson J; Kumagai K; Lundell L; Tsai JA; Lindblad M; Rouvelas I; Friesland S; Wang N; Nilsson M
Dis Esophagus; 2016 Jul; 29(5):442-7. PubMed ID: 25809837
[TBL] [Abstract][Full Text] [Related]
14. Nutritional support with endoluminal stenting during neoadjuvant therapy for esophageal malignancy.
Bower M; Jones W; Vessels B; Scoggins C; Martin R
Ann Surg Oncol; 2009 Nov; 16(11):3161-8. PubMed ID: 19636630
[TBL] [Abstract][Full Text] [Related]
15. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?
Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K
Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755
[TBL] [Abstract][Full Text] [Related]
16. TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG.
Leong T; Smithers BM; Haustermans K; Michael M; Gebski V; Miller D; Zalcberg J; Boussioutas A; Findlay M; O'Connell RL; Verghis J; Willis D; Kron T; Crain M; Murray WK; Lordick F; Swallow C; Darling G; Simes J; Wong R
Ann Surg Oncol; 2017 Aug; 24(8):2252-2258. PubMed ID: 28337660
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of the esophago-gastric junction adenocarcinoma].
Bîrlă R; Losif C; Gîndea C; Hoară P; Constantinoiu S
Chirurgia (Bucur); 2008; 103(2):143-53. PubMed ID: 18457092
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic feeding jejunostomy technique as part of staging laparoscopy.
Grondona P; Andreani SM; Barr N; Singh KK
Surg Laparosc Endosc Percutan Tech; 2005 Sep; 15(5):263-6. PubMed ID: 16215483
[TBL] [Abstract][Full Text] [Related]
19. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.
Münch S; Habermehl D; Agha A; Belka C; Combs SE; Eckel R; Friess H; Gerbes A; Nüssler NC; Schepp W; Schmid RM; Schmitt W; Schubert-Fritschle G; Weber B; Werner J; Engel J
Strahlenther Onkol; 2018 Feb; 194(2):125-135. PubMed ID: 29071366
[TBL] [Abstract][Full Text] [Related]
20. Feeding duodenostomy decreases the incidence of mechanical obstruction after radical esophageal cancer surgery.
Oya H; Koike M; Iwata N; Kobayashi D; Torii K; Niwa Y; Kanda M; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Nomoto S; Fujiwara M; Kodera Y
World J Surg; 2015 May; 39(5):1105-10. PubMed ID: 25665669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
